GGrantIndex
Sort

4,870 grants matching glp 1

Determination of Route of Administration and Cardiac Safety of a Novel Psychoplastogen for the treatment of SUDs

$319,313
Stephanie McTighe · Delix Therapeutics · R43 · FY2023 · DA

Stimulation of Tear Secretion by a Novel Glycoprotein

$319,222
John D Sheppard · Eyerx Research, Inc. · R42 · FY2007 · EY

Product Development and Manufacturing Core

$318,669
Becky L Rivoire Phd · Colorado State University · U54 · FY2010 · AI

Large Animal (Dog) experimental support module

$318,573
Gustavo David Aguirre · University Of Pennsylvania · R24 · FY2014 · EY

PCAF/GCN5 Acetylation on p53 Transactivation

$318,519
Shelley L Berger · University Of Pennsylvania · R01 · FY2013 · CA

Role of Glucokinase in GLP-1 Regulation of Energy and Glucose Homeostasis

$318,229
Darleen A Sandoval · University Of Michigan At Ann Arbor · R01 · FY2014 · DK

Epidemiology and Long-Term Effect of Cardiometabolic Medication Substitution during Post-acute Care

$318,000
Chan Mi Park · Hebrew Rehabilitation Center For Aged · R03 · FY2024 · AG

Optimizing Stage 2 T1DM Management: Assessing the Impact of GLP-1Ra on Metabolic Outcomes in Patients Receiving Teplizumab

$317,999
Justin Gregory · Vanderbilt University Medical Center · R01 · FY2024 · DK

Parallel-group randomized controlled trial of Pioglitazone versus empagliflozin for T3cDM: The PEP-DM Trial

$317,984
Yogish C. Kudva · Mayo Clinic Rochester · R01 · FY2025 · DK

FGF-2 mimetic peptides as pleuripotent mitigators of ARS and DEARE

$317,941
Paul Okunieff · University Of Maryland Baltimore · U19 · FY2020 · AI

Large Animal (Dog) experimental support module

$317,902
Gustavo David Aguirre · University Of Pennsylvania · R24 · FY2013 · EY

Engineered R-type pyocins as bactericidal agents against E.coli O157:H7

$317,576
Dean M Scholl · Avidbiotics Corporation · R43 · FY2009 · AI

Engineered R-type pyocins as bactericidal agents against E.coli O157:H7

$317,576
Dean M Scholl · Avidbiotics Corporation · R43 · FY2010 · AI

Drug Development of GLP-1 receptor agonists

$317,288
Josephine Egan · National Institute On Aging · ZIA · FY2010 · AG

Imaging beta cell function for metabolic surgery

$317,112
Paul E Harris · Columbia University Health Sciences · R01 · FY2019 · DK

Effects of Liraglutide on Gastric Functions and their Relationship to Weight Loss in Obesity

$317,078
Michael L Camilleri · Mayo Clinic Rochester · R01 · FY2020 · DK

L-type Ca2+ channel modulation of beta cell function

$316,882
Gregory Howard Hockerman · Purdue University · R01 · FY2009 · DK

Creating in vivo Chemical Probes for Lysine Methyltransferases G9a and GLP

$316,770
Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · GM

Dihydromethysticin (DHM) for Lung Cancer Chemoprevention

$316,616
Chengguo Xing · University Of Florida · R01 · FY2017 · CA

Functional & Structural Connectivity in Alcohol Use Disorder

$316,594
Reza Momenan · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA

Musculoskeletal Plasticity after Spinal Cord Injury

$316,438
Richard K Shields · University Of Iowa · R01 · FY2018 · HD

Musculoskeletal Plasticity after Spinal Cord Injury

$316,438
Richard K Shields · University Of Iowa · R01 · FY2019 · HD

Musculoskeletal Plasticity after Spinal Cord Injury

$316,438
Richard K Shields · University Of Iowa · R01 · FY2017 · HD

Neurohumoral Regulation in Diabetic Enteropathy

$316,344
Adil E. Bharucha · Mayo Clinic Rochester · P01 · FY2006 · DK

Functional characterization of endocrine taste cells

$316,155
Robert F Margolskee · Monell Chemical Senses Center · R01 · FY2010 · DC